Top

Supply of Metoprolol Tartrate Active Pharmaceutical Ingredient (API)

Active

Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)View Agency

NAICS

325411 - Medicinal and Botanical ManufacturingView NAICS

Place of Performance

Set-Aside

NONE

Documents

This scope was carved out of 36E79725R0071.

The full solicitation package (3 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

6505--Metoprolol Tartrate IR Tablets Effective 5/8/2026 - 5/7/2027

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedFeb 4

subcontract

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Supply of USP-grade bulk Metoprolol Tartrate API for formulation, with CoA and compliance with Buy American requirements.

Similar Contracts

Same NAICS industry code

Solicitation # SPE2DP-26-T-5144

This Request for Quotations (RFQ) issued by DLA Troop Support Medical Supply Chain Pharm FSA involves the procurement of Carboprost Tromethamine Injection, USP 250 MCG/ML, consisting of 10 x 1ML single-dose vials. The medication is intended for intramuscular use only and requires strict temperature control, as it must be refrigerated between 2 to 8 C (36 to 46 F). The contract is a fixed-price acquisition for one box, with delivery required to a destination in the Joint Region Marianas, Guam, or via APO AP. The item has a non-extendable shelf life of 24 months. The procurement is subject to rigorous medical packaging and marking standards. All units must be packaged in suitable, sealed commercial containers to prevent damage and marked in accordance with Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must adhere to MIL-STD-2073-1E and DLA packaging requirements, including specific palletization protocols. As an FDA-regulated drug, the contracting official must confirm product details with a specialist. Compliance with various federal regulations is required, including the Buy American Act, the prohibition on trafficking in persons, and cybersecurity standards for safeguarding covered defense information. Quotations must be submitted through the DLA Internet Bid Board System (DIBBS).

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Medical Item NSN 6505-01-675-5990This subcontract involves the supply of medical products for prime contractors supporting Department of Defense DLA supply contracts. The specific requirement is for the manufacture or sourcing of 10 cases of medical item NSN 6505-01-675-5990, ensuring all items meet strict technical specifications. The contract is managed by the Medical Supply Chain Pharm FSA and requires full compliance with the Buy American and Balance of Payments Program. The performance of this contract will take place at Camp Pendleton, California. Interested parties must respond by September 22, 2026, following the posting date of September 16, 2026. The procurement falls under NAICS code 325411 and is focused on the delivery of the specified medical quantity to meet agency needs.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

BENZOCAINE AND MENTHOL

Solicitation # SPE2DP-26-T-5137

Solicitation SPE2DP-26-T-5137 is a request for quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of Cepacol Extra Strength Sore Throat Honey Lemon Lozenges. The product is an oral pain reliever containing 15mg of Benzocaine and 2.6mg of Menthol, provided in packages of 16. The requirement consists of two line items with quantities of 30 and 3 packages respectively, under NSN 6505017081449. Delivery is required within 10 days after receipt of order, with specific delivery dates set for July 30, 2025, and September 18, 2026. Shipping destinations include Camp Pendleton, California, and Vilseck, Germany, with terms set as FOB Destination. The contract mandates strict adherence to medical packaging and marking standards. All materials must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercial, utilizing sealed unit containers to prevent damage and exterior shipping containers suitable for safe delivery. Palletization must comply with DLA packaging requirements RP001. The items are classified as Type I (Code Q) with a non-extendable shelf life of 36 months and must be stored between 20-25 degrees Celsius. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and compliance with various FAR and DFARS clauses regarding cybersecurity, human trafficking, and domestic material restrictions.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

CHLORHEXIDINE GLUCONAT

Solicitation # SPE2DP-26-T-5140

This solicitation, issued by the DLA Troop Support Medical Supply Chain, is a Request for Quotations for the procurement of Chlorhexidine Gluconate Cleansing Solution (NSN 6505-01-675-5990). The requirement consists of 20 cases in total, split across two line items of 10 cases each, with each case containing 8 bottles of 16oz surgical scrub. The product has a total shelf life of 24 months, and items must have a minimum of 321 months of remaining shelf life upon receipt by the first government activity. The material is flammable and must be stored between 20-25 C. Delivery is required by September 18, 2026, with shipping terms set as FOB Destination for both inspection and acceptance at Camp Pendleton, California. Packaging must be commercial, utilizing sealed unit containers and exterior shipping containers. Marking and labeling must strictly adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Because the material may be considered hazardous, suppliers must provide Safety Data Sheets (SDS) and labels consistent with 29 C.F.R. 1910.1200. The procurement falls under NAICS 325411 and incorporates various FAR and DFARS clauses, including the Buy American and Balance of Payments Program and safeguarding requirements for covered defense information. Quotes must be submitted via the DIBBS system by September 22, 2026. Payment and receiving reports are to be processed electronically through the Wide Area WorkFlow (WAWF) system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Double-Back Tape (NSN 8030-01-558-3169)

Navsup Weapon Systems Support Mech

POSTED

DEADLINE

PLASMA-LYTE A INJECTIO

Solicitation # SPE2DP-26-T-5119

Solicitation SPE2DP-26-T-5119 is a fixed-price request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of 10 units of Plasma-Lyte A Injection (NSN 6505017089039). The product consists of a 500 mL VIAFLEX plastic container of pH 7.4 multiple electrolytes injection, which must be stored at room temperature. The required delivery date is September 17, 2026, with a delivery window of 10 days after the order. Shipping is FOB Destination, with both inspection and acceptance occurring at the destination in Vilseck, Germany. The contractor must adhere to strict packaging and marking standards, utilizing commercial packaging in sealed unit containers and exterior shipping containers. Marking must comply with Medical Marking Standard No. 1, which supersedes MIL-STD-129. Palletization must follow DLA requirement RP001. The item is classified as a Type I (Code J) item with a non-extendable shelf life of 15 months. Administrative requirements include the use of the Wide Area WorkFlow (WAWF) system for invoicing and compliance with various FAR and DFARS clauses, including the Buy American Act, Berry Amendment, and cybersecurity reporting under DFARS 252.204-7012. Quotations must be submitted via the DIBBS portal by September 21, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Opaque Black Rubber Adhesive TapeThis subcontract opportunity is for the supply of 498 rolls of opaque black adhesive rubber tape to support prime contractors delivering DLA supply contracts for the Department of Defense Nuclear Reactor Program. The tape must meet specific nominal dimensions of 0.0310 inches in thickness and 1.0 inch in width, with each roll containing 216 feet of material. All supplies must comply with shelf-life requirement RS001 and NSN 004490807/9320, ensuring a minimum shelf life of 24 months. The contract is designated as a Women-Owned Small Business set-aside under NAICS code 325411. Performance will take place in Bremerton, Washington. Interested parties must respond by September 25, 2026, following the posting date of September 14, 2026.

NUCLEAR REACTOR PROGRAM

POSTED

DEADLINE

Magnesium Sulfate SupplierThis subcontract under the Department of Defense Medical Supply Chain Pharm FSA requires the supply of pharmaceutical-grade Magnesium Sulfate meeting NSN 6505017144975 specifications. The product must be provided as a Type I Code Q item with a non-extendable shelf life of 36 months, utilizing commercial packaging. The scope of work involves the delivery of one case of the material to the designated government location in FPO 09520. The opportunity is categorized under NAICS code 325411 and was posted on September 13, 2026, with a response deadline of September 21, 2026. This contract is intended for prime contractors supporting medical supply chain projects.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Hydrocortisone Cream 2.5%This subcontract through the Department of Defense Medical Supply Chain Pharm FSA involves the procurement of pharmaceutical-grade Hydrocortisone Cream at a 2.5 percent concentration. The selected provider is responsible for manufacturing or sourcing the cream in 1 oz medical-grade tubes, ensuring full compliance with FDA and GMP pharmaceutical manufacturing standards as well as specific NSN requirements. The contract requires the delivery of 15 units of 1 oz tubes to a designated DLA facility located at Fort Stewart, Georgia. This opportunity falls under NAICS code 325411 and is intended for prime contractors supporting DLA Troop Support Medical Supply Chain operations, with a response deadline of September 21, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

NORGESTIMATE AND ETHIN

Solicitation # SPE2DP-26-T-5029

Solicitation SPE2DP-26-T-5029 is a request for quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of norgestimate and ethinyl estradiol tablets, identified by NSN 6505016663685. The requirement consists of two line items, each for one package of 6 cycles containing 168 tablets. The drug is FDA regulated and must be stored at 25 degrees C, with permitted excursions between 15 and 30 degrees C, and must be protected from light. The items carry a non-extendable shelf life of 36 months. Delivery is required within 20 days of order, with original required delivery dates set for September 14 and 15, 2026. Shipping is FOB Destination to locations in Germany and Georgia. The contract mandates strict adherence to DLA packaging and marking standards, including MIL-STD-129 and Medical Marking Standard No. 1. Packaging must follow ASTM D3951 for non-hazardous materials or TQ requirement IP025 for hazardous materials, with all palletization complying with RP001. Inspection and acceptance will occur at the destination. Offerors must comply with the Buy American Act and the Berry Amendment, and the resulting award will be a DX or DO rated order under the Defense Priorities and Allocations System. Invoicing and payment must be processed through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-5032

Solicitation SPE2DP-26-T-5032 is a fixed-price request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Hydrocortisone Cream, 2.5% concentration in 1 oz tubes (NSN 6505017157536). The requirement consists of two line items: CLIN 0001 for 15 units and CLIN 0002 for 300 units. The product is FDA-regulated and must be stored at 20 to 25 degrees Celsius and protected from freezing. A non-extendable shelf life of 24 months is required. Delivery is set for 20 days after the award, with an original required delivery date of September 14, 2026. Shipping is FOB Destination to Fort Stewart, Georgia, via the fastest traceable means. Packaging must be commercial and compliant with MIL-STD-2073-1E and RP001, while marking must strictly adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Inspection and acceptance will occur at the destination. The solicitation incorporates the DLA Master Solicitation for Automated Simplified Acquisitions Revision 105 and requires submissions through the DIBBS system by September 21, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

BENZOCAINE AND MENTHOL

Solicitation # SPE2DP-26-T-5057

Solicitation SPE2DP-26-T-5057, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is a request for quotations for the acquisition of 4 packages of Cepacol Extra Strength Sore Throat Honey Lemon Lozenges. Each unit contains 15mg of Benzocaine and 2.6mg of Menthol and is provided in packages of 16. The items are identified by NSN 6505017081449 and must be delivered FOB Destination to Rose Barracks in Vilseck, Germany, within 5 days after order. The original required delivery date is September 15, 2026. The contract mandates strict adherence to medical packaging and marking standards. All materials must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercial, utilizing suitable sealed unit containers and exterior shipping containers to prevent damage, with palletization following DLA requirement RP001. The product must be stored at 20-25 C (68-77 F) and protected from humidity. Additionally, the item is classified as a Type I (Code Q) item with a non-extendable shelf life of 36 months. Administrative requirements include the use of Wide Area Workflow (WAWF) for electronic invoicing and payment requests. The solicitation incorporates various FAR and DFARS clauses, including those regarding the Buy American Act, safeguarding covered defense information, and combating trafficking in persons. Quotes must be submitted via the DIBBS system by September 21, 2026. Inspection and acceptance will occur at the destination.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

6 days ago

DEADLINE

in 2 days

View Details

More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Same awarding agency

NAICS: 424210

New

Federal

Pharmaceutical Distribution ServicesThis subcontract for Pharmaceutical Distribution Services involves the supply and distribution of Glipizide Tablets to prime contractors supporting various government entities, including the VA, DoD, BOP, IHS, and FHCC. The scope of work encompasses comprehensive warehousing, inventory management, and FOB Destination shipping specifically tailored for Consolidated Mail Order Pharmacies and State Veterans Homes. To ensure product integrity, the operations utilize climate-controlled warehousing and specialized pharmaceutical transport vehicles for delivery to designated government destinations. Managed by Nac Pharmaceuticals under the Department of Veterans Affairs, the contract falls under NAICS code 424210, with a response deadline set for October 8, 2026.

Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

DEADLINE

Pharmaceutical Packaging and Labeling ServicesThis subcontract for Pharmaceutical Packaging and Labeling Services involves the packaging and labeling of Glipizide Tablets to support prime contractors delivering pharmaceutical supplies to the VA, DoD, BOP, IHS, and FHCC. The scope of work includes bottling, blister packing, and the application of labels that meet specific VA and DoD requirements using specialized pharmaceutical machinery. All operations must strictly adhere to FDA cGMP standards and the requirements outlined in Section 5 of the contract scope to ensure the tablets are ready for final shipment. This opportunity is issued by Nac Pharmaceuticals under the Department of Veterans Affairs, with a response deadline of October 8, 2026.

All Other Miscellaneous Manufacturing

POSTED

DEADLINE

Glipizide Tablet ManufacturingNac Pharmaceuticals is seeking a subcontractor for the manufacturing of Glipizide Tablets to support pharmaceutical supply contracts for the Department of Veterans Affairs, DoD, BOP, IHS, and FHCC. The scope of work encompasses the entire production process, including the chemical synthesis of the active pharmaceutical ingredient, tablet formulation, compression, and rigorous quality control testing. The selected provider must utilize pharmaceutical grade manufacturing equipment and maintain strict compliance with FDA cGMP standards. Key deliverables include the finished Glipizide Tablets and the provision of an 11-digit National Drug Code number. This subcontract opportunity falls under NAICS code 325412, with a response deadline of October 8, 2026.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

6505--Glipizide Tablets

Solicitation # 36E79726R0031_1

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

6505--2027-2028 Influenza Virus Vaccine

Solicitation # 36E79726R0035

Solicitation 36E79726R0035 is an unrestricted FAR Part 12 commercial-item procurement issued by the Department of Veterans Affairs National Acquisition Center for the supply of Influenza Virus Vaccines for the 2027-2028 season. The contract requires the delivery of trivalent or quadrivalent vaccines in pre-filled single-dose syringes with plunger and Luer lock needle attachments, provided in boxes of 10. The vaccines must be latex and preservative free, with specific FDA approval and labeling required for pediatric populations (6 to 35 months) and seniors (65 years and older). Final vaccine presentation is based on World Health Organization recommendations, with a preference for Trivalent presentations if both Trivalent and Quadrivalent options are commercially available. The award will be made on a per solicitation line item basis for the VA, Bureau of Prisons, Indian Health Service, and the Captain James A. Lovell Federal Health Care Center. Deliveries are Free On Board Destination to government facilities across the United States, Puerto Rico, and the Philippines. Most facilities require a two-part delivery schedule, with at least 50 percent of the order delivered between August 15 and September 15, 2027, and the remainder by October 15, 2027; however, the FHCC must receive 100 percent of its awarded quantity by September 15, 2027. Offerors must provide the full quantity for any line item bid, and final pricing must include the Cost Recovery Fee and Federal Excise Tax.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Pharmaceutical Distribution and FulfillmentThis subcontract for Pharmaceutical Distribution and Fulfillment, managed by Nac Pharmaceuticals for the Department of Veterans Affairs, focuses on the storage and shipment of Lisinopril tablets. The provider is responsible for the warehousing of finished products using climate-controlled facilities and logistics management software to support the Department of Veterans Affairs and DoD Pharmaceutical Prime Vendor Program projects. The scope of work includes coordinating FOB Destination shipments to federal health centers, CMOPs, and TMOPs, ensuring the product is delivered to all designated distribution points. This opportunity falls under NAICS code 423450, with a response deadline set for September 24, 2026.

Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

DEADLINE

Pharmaceutical Packaging and Labeling ServicesThis subcontract for Pharmaceutical Packaging and Labeling Services involves the filling, labeling, and primary packaging of Lisinopril tablets to support Department of Veterans Affairs pharmaceutical supply projects. The selected provider will be responsible for filling intermediate containers and applying compliant labels, including 11-digit NDC numbers, within a sterile or controlled packaging environment to ensure the tablets are ready for distribution. To qualify for this engagement with Nac Pharmaceuticals, the contractor must possess a valid FEI number and maintain strict FDA cGMP compliance for packaging. The opportunity was posted on September 3, 2026, with a response deadline of September 24, 2026, falling under NAICS code 325412.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Lisinopril Tablet ManufacturingNac Pharmaceuticals is seeking a subcontractor for the manufacturing of Lisinopril tablets to support Department of Veterans Affairs pharmaceutical supply projects. The selected provider will be responsible for the entire production process, including the chemical synthesis of the active pharmaceutical ingredient, formulation, compression into tablets, and rigorous quality control testing in accordance with ACS and USP-NF specifications. To qualify, the manufacturer must operate FDA-compliant cGMP facilities and possess a valid FEI number to ensure the delivery of bulk finished tablets that meet all purity and potency standards. This subcontract opportunity was posted on September 3, 2026, with a response deadline of September 24, 2026, falling under NAICS code 325412.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

36E79726R0032 Lisinopril Tablets (VA-27-00004937)

Solicitation # 36E79726R0032

The Department of Veterans Affairs, through the National Acquisition Center, is soliciting proposals for an unrestricted contract to provide an uninterrupted source of supply for Lisinopril Tablets. This procurement supports multiple federal health agencies, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers, with distribution managed via the VA and DOD Pharmaceutical Prime Vendor Programs. The contract consists of a one-year base period with four pre-priced one-year option periods. Award will be made to a single responsible offeror based on an aggregate evaluation of all 22 line items across the base and option years. The scope of work includes the delivery of Lisinopril in strengths of 2.5mg, 5mg, 10mg, 20mg, 30mg, and 40mg across various package sizes. Strict packaging and labeling requirements are mandated, including the use of a unique NDC number, specific cylindrical bottle dimensions with a minimum 120cc volume and 5.75 inch circumference, and safety-caps that are either convertible or deshellable. Labels must be compatible with VA labels and fit specific dimensions of 5.25 by 2 inches. Offers are due by September 24, 2026, at 2:30 PM CST, and must include pricing for all line items and a 0.5 percent cost recovery fee.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Pharmaceutical Logistics and Distribution to Prime Vendors

General Warehousing and Storage

POSTED

DEADLINE

NDC Registration and FDA Compliance Services

Administrative Management and General Management Consulting Services

POSTED

DEADLINE

Primary and Secondary Packaging of Prescription Medications

In-Vitro Diagnostic Substance Manufacturing

POSTED

8 months ago

DEADLINE

N/A

View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS